ReviewRSC advances2026
Metal-based triazoles as a medical marvel of the modern era: a comprehensive review.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance is raising serious health concerns across the globe, and its adverse effects are elevating day by day. Researchers are making efforts to find new and more efficient pharmaceutical agents to overcome this growing challenge. Metal-based drugs are very useful in this regard, and hence, they are gaining more attention from researchers. This review systematically examines metal-based triazole Schiff base compounds, delving into their synthetic methodologies, structural characterization and a range of bioactivities. With a precise emphasis on antimicrobial properties along with cytotoxicity effects, DNA interactions and anti-cancerous and enzymatic applications, researches explores that these compounds are innovative solutions to the growing crisis of antimicrobial resistance. The synergistic combination of metal ions and organic ligands within these complexes often results in enhanced antimicrobial efficacy compared to traditional organic antimicrobials. This review provides a comprehensive overview of triazole-based metal complexes under research from 2006 to 2024, which can be used as antibacterial, antifungal, cytotoxic, anticancer, DNA interaction and enzyme inhibition agents.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.